FDA Approves Imfinzi Regimen for Bladder Cancer Patients Who Cannot Take Cisplatin
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
People with muscle-invasive bladder cancer who cannot receive or have refused cisplatin-based chemotherapy now have a newly cleared U.S. treatment…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
5 confirmed facts, 2 open questions and 2 sources behind this story.